{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:57:20Z","timestamp":1791050240954,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Foundation of Affiliated Hospital of Nantong University","award":["(BSH202203, Tdb2107)"],"award-info":[{"award-number":["(BSH202203, Tdb2107)"]}]},{"name":"Foundation of Jiangsu Province Research Hospital","award":["YJXYY202204-XKB17"],"award-info":[{"award-number":["YJXYY202204-XKB17"]}]},{"name":"The Science and Technology Project of Nantong City","award":["(MS22022111)"],"award-info":[{"award-number":["(MS22022111)"]}]},{"name":"Project of the 14th Five Year Plan for Strengthening Science, Education, and Health of Nantong City, Cancer Clinical Medical Center","award":["(NTYXZX18)"],"award-info":[{"award-number":["(NTYXZX18)"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China Grants","doi-asserted-by":"crossref","award":["(No.81570184)"],"award-info":[{"award-number":["(No.81570184)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Province Capability Improvement Project through Science, Technology and Education","award":["(ZDXK202234)"],"award-info":[{"award-number":["(ZDXK202234)"]}]},{"name":"The 2024 Provincial Basic Research Special Fund (Natural Science Foundation) General Project: The Role and Mechanism of Abnormal Arginine Metabolism in the Progression of Peripheral T-cell Lymphoma","award":["(BK20241837)"],"award-info":[{"award-number":["(BK20241837)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-024-01582-2","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T05:25:33Z","timestamp":1732253133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significance and expression of SLC35F6 in bladder urothelial carcinoma"],"prefix":"10.1186","volume":"19","author":[{"given":"Jinling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"2","key":"1582_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41585-020-00394-5","volume":"18","author":"EI Heath","year":"2021","unstructured":"Heath EI, Rosenberg JE. The biology and rationale of targeting nectin-4 in urothelial carcinoma. Nat Reviews Urol. 2021;18(2):93\u2013103.","journal-title":"Nat Reviews Urol"},{"issue":"5","key":"1582_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"Cancer J Clin"},{"issue":"2","key":"1582_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","volume":"69","author":"J Dobruch","year":"2016","unstructured":"Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, et al. Gender and bladder Cancer: a collaborative review of etiology, Biology, and outcomes. Eur Urol. 2016;69(2):300\u201310.","journal-title":"Eur Urol"},{"issue":"1","key":"1582_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-022-01291-7","volume":"15","author":"N Xu","year":"2022","unstructured":"Xu N, Yao Z, Shang G, Ye D, Wang H, Zhang H, et al. Integrated proteogenomic characterization of urothelial carcinoma of the bladder. J Hematol Oncol. 2022;15(1):76.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1582_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupr\u00eat","year":"2021","unstructured":"Roupr\u00eat M, Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, et al. European Association of Urology Guidelines on Upper urinary tract Urothelial Carcinoma: 2020 update. Eur Urol. 2021;79(1):62\u201379.","journal-title":"Eur Urol"},{"key":"1582_CR6","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3389\/fonc.2019.01533","volume":"9","author":"J Cao","year":"2019","unstructured":"Cao J, Yang X, Li J, Wu H, Li P, Yao Z, et al. Screening and identifying Immune-related cells and genes in the Tumor Microenvironment of bladder Urothelial Carcinoma: based on TCGA Database and Bioinformatics. Front Oncol. 2019;9:1533.","journal-title":"Front Oncol"},{"issue":"10","key":"1582_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","volume":"15","author":"C Pettenati","year":"2018","unstructured":"Pettenati C, Ingersoll MA. Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nat Reviews Urol. 2018;15(10):615\u201325.","journal-title":"Nat Reviews Urol"},{"issue":"4","key":"1582_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"1582_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78(4):770\u201382.","journal-title":"J Hepatol"},{"issue":"2","key":"1582_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/cas.15202","volume":"113","author":"PC Wang","year":"2022","unstructured":"Wang PC, Hu ZQ, Zhou SL, Yu SY, Mao L, Su S, et al. The spatial distribution of immune cell subpopulations in hepatocellular carcinoma. Cancer Sci. 2022;113(2):423\u201331.","journal-title":"Cancer Sci"},{"issue":"4","key":"1582_CR11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA. Therapeutic targeting of the Tumor Microenvironment. Cancer Discov. 2021;11(4):933\u201359.","journal-title":"Cancer Discov"},{"issue":"1","key":"1582_CR12","doi-asserted-by":"publisher","first-page":"1746573","DOI":"10.1080\/2162402X.2020.1746573","volume":"9","author":"F Liu","year":"2020","unstructured":"Liu F, Liu W, Sanin DE, Jia G, Tian M, Wang H, et al. Heterogeneity of exhausted T cells in the tumor microenvironment is linked to patient survival following resection in hepatocellular carcinoma. Oncoimmunology. 2020;9(1):1746573.","journal-title":"Oncoimmunology"},{"key":"1582_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/978-3-030-59038-3_17","volume":"1296","author":"K Hatogai","year":"2020","unstructured":"Hatogai K, Sweis RF. The Tumor Microenvironment of bladder Cancer. Adv Exp Med Biol. 2020;1296:275\u201390.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"1582_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1349-7006.2008.01058.x","volume":"100","author":"K Kashiwaya","year":"2009","unstructured":"Kashiwaya K, Hosokawa M, Eguchi H, Ohigashi H, Ishikawa O, Shinomura Y, et al. Identification of C2orf18, termed ANT2BP (ANT2-binding protein), as one of the key molecules involved in pancreatic carcinogenesis. Cancer Sci. 2009;100(3):457\u201364.","journal-title":"Cancer Sci"},{"issue":"1","key":"1582_CR15","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1038\/s41467-024-51860-2","volume":"15","author":"W Zhao","year":"2024","unstructured":"Zhao W, Wang X, Han L, Zhang C, Wang C, Kong D, et al. SLC13A3 is a major effector downstream of activated \u03b2-catenin in liver cancer pathogenesis. Nat Commun. 2024;15(1):7522.","journal-title":"Nat Commun"},{"key":"1582_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2022.05.022","volume":"188","author":"A Flierl","year":"2022","unstructured":"Flierl A, Schriner SE, Hancock S, Coskun PE, Wallace DC. The mitochondrial adenine nucleotide transporters in myogenesis. Free Radic Biol Med. 2022;188:312\u201327.","journal-title":"Free Radic Biol Med"},{"issue":"13","key":"1582_CR17","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1038\/sj.onc.1207392","volume":"23","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, et al. Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene. 2004;23(13):2385\u2013400.","journal-title":"Oncogene"},{"key":"1582_CR18","doi-asserted-by":"crossref","unstructured":"Cheng T, Xu M, Zhang H, Lu B, Zhang X, Wang Z et al. KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma. Oxidative medicine and cellular longevity. 2022;2022:2694377.","DOI":"10.1155\/2022\/2694377"},{"key":"1582_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jare.2021.11.010","volume":"39","author":"S Liu","year":"2022","unstructured":"Liu S, Chen X, Lin T. Emerging strategies for the improvement of chemotherapy in bladder cancer: current knowledge and future perspectives. J Adv Res. 2022;39:187\u2013202.","journal-title":"J Adv Res"},{"issue":"3","key":"1582_CR20","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","volume":"162","author":"A C\u00e9sar-Razquin","year":"2015","unstructured":"C\u00e9sar-Razquin A, Snijder B, Frappier-Brinton T, Isserlin R, Gyimesi G, Bai X, et al. A call for systematic research on Solute Carriers. Cell. 2015;162(3):478\u201387.","journal-title":"Cell"},{"issue":"9","key":"1582_CR21","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1111\/febs.15531","volume":"288","author":"MD Pizzagalli","year":"2021","unstructured":"Pizzagalli MD, Bensimon A, Superti-Furga G. A guide to plasma membrane solute carrier proteins. FEBS J. 2021;288(9):2784\u2013835.","journal-title":"FEBS J"},{"key":"1582_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/cancers16183226","volume":"16","author":"SY Cho","year":"2024","unstructured":"Cho SY, Kang NS. The solute carrier (SLC) Transporter Superfamily as therapeutic targets for the treatment of Head and Neck squamous cell carcinoma. Cancers. 2024;16:18.","journal-title":"Cancers"},{"issue":"7","key":"1582_CR23","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00406-023-01576-z","volume":"273","author":"H Rosenbrock","year":"2023","unstructured":"Rosenbrock H, Desch M, Wunderlich G. Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia. Eur Arch Psychiatry Clin NeuroSci. 2023;273(7):1557\u201366.","journal-title":"Eur Arch Psychiatry Clin NeuroSci"},{"issue":"11","key":"1582_CR24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/ng.3105","volume":"46","author":"JR Cerhan","year":"2014","unstructured":"Cerhan JR, Berndt SI, Vijai J, Ghesqui\u00e8res H, McKay J, Wang SS, et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet. 2014;46(11):1233\u20138.","journal-title":"Nat Genet"},{"key":"1582_CR25","doi-asserted-by":"crossref","unstructured":"Chen J, Jiang Y, Hou M, Liu C, Liu E, Zong Y et al. Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC. Gut. 2024.","DOI":"10.1136\/gutjnl-2024-332902"},{"issue":"12","key":"1582_CR26","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/ng.3685","volume":"48","author":"C Lesseur","year":"2016","unstructured":"Lesseur C, Diergaarde B, Olshan AF, W\u00fcnsch-Filho V, Ness AR, Liu G, et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet. 2016;48(12):1544\u201350.","journal-title":"Nat Genet"},{"key":"1582_CR27","doi-asserted-by":"crossref","unstructured":"Wo\u0142\u0105cewicz M, Hrynkiewicz R, Grywalska E, Suchojad T, Leksowski T, Roli\u0144ski J et al. Immunotherapy in bladder Cancer: current methods and future perspectives. Cancers. 2020;12(5).","DOI":"10.3390\/cancers12051181"},{"issue":"7","key":"1582_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/PAS.0000000000001264","volume":"43","author":"H Reis","year":"2019","unstructured":"Reis H, Serrette R, Posada J, Lu V, Chen YB, Gopalan A, et al. PD-L1 expression in Urothelial Carcinoma with predominant or pure variant histology: Concordance among 3 commonly used and commercially available antibodies. Am J Surg Pathol. 2019;43(7):920\u20137.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"1582_CR29","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S1470-2045(17)30616-2","volume":"18","author":"AV Balar","year":"2017","unstructured":"Balar AV, Castellano D, O\u2019Donnell PH, Grivas P, Vuky J, Powles T, et al. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017;18(11):1483\u201392.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1582_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1470-2045(17)30065-7","volume":"18","author":"P Sharma","year":"2017","unstructured":"Sharma P, Retz M, Siefker-Radtke A, Baron A, Necchi A, Bedke J, et al. Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2017;18(3):312\u201322.","journal-title":"Lancet Oncol"},{"issue":"10364","key":"1582_CR31","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet (London England). 2022;400(10364):1712\u201321.","journal-title":"Lancet (London England)"},{"issue":"4","key":"1582_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","volume":"14","author":"SP Patel","year":"2015","unstructured":"Patel SP, Kurzrock R. PD-L1 expression as a predictive biomarker in Cancer Immunotherapy. Mol Cancer Ther. 2015;14(4):847\u201356.","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"1582_CR33","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1093\/annonc\/mdy335","volume":"29","author":"L Par\u00e9","year":"2018","unstructured":"Par\u00e9 L, Pascual T, Segu\u00ed E, Teixid\u00f3 C, Gonzalez-Cao M, Galv\u00e1n P, et al. Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types. Annals Oncology: Official J Eur Soc Med Oncol. 2018;29(10):2121\u20138.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-024-01582-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T08:24:42Z","timestamp":1732263882000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-024-01582-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1582"],"URL":"https:\/\/doi.org\/10.1186\/s13000-024-01582-2","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"5 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The informed consent of all patients was obtained before the study. The Ethics Committee of the Affiliated Hospital of Nantong University approved this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}